Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases
Open Access
- 12 July 2019
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 38 (30) , 5905-5920
Abstract
Deregulation of cyclin-dependent kinases 4 and 6 (CDK4/6) is highly prevalent in cancer; yet, inhibitors against these kinases are currently used only in restricted tumour contexts. The extent to which cancers depend on CDK4/6 and the mechanisms that may undermine such dependency are poorly understood. Here, we report that signalling engaging the MET proto-oncogene receptor tyrosine kinase/focal adhesion kinase (FAK) axis leads to CDK4/6-independent CDK2 activation, involving as critical mechanistic events loss of the CDKI p21CIP1 and gain of its regulator, the ubiquitin ligase subunit SKP2. Combined inhibition of MET/FAK and CDK4/6 eliminates the proliferation capacity of cancer cells in culture, and enhances tumour growth inhibition in vivo. Activation of the MET/FAK axis is known to arise through cancer extrinsic and intrinsic cues. Our work predicts that such cues support cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases and identifies MET/FAK as a tractable route to broaden the utility of CDK4/6 inhibitor-based therapies in the clinic.Keywords
All Related Versions
Funding Information
- Cancer Research UK (C423/A1421, C423/A15043, C309/A11566, C368/A6743, A368/A7990, C309/A11566, C368/A6743, A368/A7990)
- World Cancer Research Fund (12-1280)
- Wellcome (094885/Z/10/Z)
This publication has 52 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Mechanism-Based Screen Establishes Signalling Framework for DNA Damage-Associated G1 Checkpoint ResponsePLOS ONE, 2012
- Targeting stroma to treat cancersSeminars in Cancer Biology, 2012
- PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitroBreast Cancer Research, 2009
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancerNature Reviews Cancer, 2008
- The Met tyrosine kinase receptor in development and cancerCancer and Metastasis Reviews, 2008
- Putting Transcription Repression and Protein Destruction in pRb's PocketDevelopmental Cell, 2007
- Focal Adhesion Kinase Controls Cellular Levels of p27/Kip1 and p21/Cip1 through Skp2-Dependent and -Independent MechanismsMolecular and Cellular Biology, 2006
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000